Literature DB >> 29503211

A demographic projection of the contribution of assisted reproductive technologies to world population growth.

Malcolm J Faddy1, Matthew D Gosden2, Roger G Gosden3.   

Abstract

Enormous unmet needs for infertility treatment exist because access to assisted reproductive technologies is demographically skewed. Since the first IVF baby in 1978, the number of people conceived by reproductive technology has grown much faster than expected, reaching several million today and rapidly approaching 0.1% of the total world population. As more patients build families, and their children in turn become parents, the number owing their existence to assisted reproductive technologies, either directly or indirectly, will expand tremendously in future decades, but no attempts have been made hitherto to project the magnitude. We have projected growth to the year 2100, along with the fractional contribution to world population. The chief variable driving growth is access to fertility services. If it stagnates at current levels of about 400,000 babies per year, an estimated 157 million people alive at the end of the century will owe their lives to assisted reproductive technologies (1.4% of global population), but at an arbitrary upper limit of 30,000 extra births annually there will be 394 million additional people alive (3.5%). As the conquest of infertility continues, individuals who owe their lives to assisted reproductive technologies will quietly make a significant contribution to demographic growth as well as social progress.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Assisted reproductive technologies; Demography; IVF; Infertility; United Nations; World population

Mesh:

Year:  2018        PMID: 29503211     DOI: 10.1016/j.rbmo.2018.01.006

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  16 in total

Review 1.  Genetics and Epigenetics of Infertility and Treatments on Outcomes.

Authors:  Margareta D Pisarska; Jessica L Chan; Kate Lawrenson; Tania L Gonzalez; Erica T Wang
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

2.  Tauroursodeoxycholic acid (TUDCA) enhanced intracytoplasmic sperm injection (ICSI) embryo developmental competence by ameliorating endoplasmic reticulum (ER) stress and inhibiting apoptosis.

Authors:  Tengfei Deng; Juanke Xie; Hengtao Ge; Qi Liu; Xiaobing Song; Lin Hu; Li Meng; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2019-12-04       Impact factor: 3.412

3.  Differential gene expression during placentation in pregnancies conceived with different fertility treatments compared with spontaneous pregnancies.

Authors:  Bora Lee; Alex F Koeppel; Erica T Wang; Tania L Gonzalez; Tianyanxin Sun; Lindsay Kroener; Yayu Lin; Nikhil V Joshi; Tejal Ghadiali; Stephen D Turner; Stephen S Rich; Charles R Farber; Jerome I Rotter; Yii-Der Ida Chen; Mark O Goodarzi; Seth Guller; Bryna Harwood; Tania B Serna; John Williams; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2019-01-02       Impact factor: 7.329

Review 4.  Transitioning from Infertility-Based (ART 1.0) to Elective (ART 2.0) Use of Assisted Reproductive Technologies and the DOHaD Hypothesis: Do We Need to Change Consenting?

Authors:  Paolo Rinaudo; Amanda Adeleye
Journal:  Semin Reprod Med       Date:  2019-03-13       Impact factor: 1.303

5.  The need to restore generative identity in women undergoing assisted reproductive technology: Development and psychometric validation of the fertility reparation inventory.

Authors:  Andrea Caputo; Viviana Langher; Oriana Capri; Ludovico Muzii; Fabiola Fedele
Journal:  J Clin Psychol       Date:  2021-11-04

6.  Unscrambling the oocyte and the egg: clarifying terminology of the female gamete in mammals.

Authors:  Francesca E Duncan; Karen Schindler; Richard M Schultz; Cecilia S Blengini; Paula Stein; Stephen A Stricker; Gary M Wessel; Carmen J Williams
Journal:  Mol Hum Reprod       Date:  2020-11-01       Impact factor: 4.518

Review 7.  Nanoparticles in pregnancy: the next frontier in reproductive therapeutics.

Authors:  Natasha Pritchard; Tu'uhevaha Kaitu'u-Lino; Lynda Harris; Stephen Tong; Natalie Hannan
Journal:  Hum Reprod Update       Date:  2021-02-19       Impact factor: 17.179

8.  Extracellular vesicles and melatonin benefit embryonic develop by regulating reactive oxygen species and 5-methylcytosine.

Authors:  Pengxiang Qu; Shiwei Luo; Yue Du; Yanru Zhang; Xiaojie Song; Xuetao Yuan; Zujie Lin; Yuchen Li; Enqi Liu
Journal:  J Pineal Res       Date:  2020-02-16       Impact factor: 13.007

9.  Increased blood pressure and impaired endothelial function after accelerated growth in IVF/ICSI children.

Authors:  H Zandstra; A P A van Montfoort; J C M Dumoulin; L J I Zimmermann; R N M Touwslager
Journal:  Hum Reprod Open       Date:  2020-01-07

Review 10.  Tracking research trends and hotspots in sperm DNA fragmentation testing for the evaluation of male infertility: a scientometric analysis.

Authors:  Saradha Baskaran; Ashok Agarwal; Manesh Kumar Panner Selvam; Renata Finelli; Kathy Amy Robert; Concetta Iovine; Peter Natesan Pushparaj; Luna Samanta; Avi Harlev; Ralf Henkel
Journal:  Reprod Biol Endocrinol       Date:  2019-12-26       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.